A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatment or with T315I Mutation

SIMPLE SUMMARY: Many patients with chronic-phase chronic myeloid leukemia (CP-CML) treated with a tyrosine kinase inhibitor (TKI) experience disease progression and switch to another TKI, but each switch yields diminishing returns. To gain insight into the burden of repeated TKI treatment failures,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolini, Franck-Emmanuel, Huguet, Françoise, Huynh, Lynn, Xu, Churong, Bouvier, Christophe, Yocolly, Aurore, Etienne, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453285/
https://www.ncbi.nlm.nih.gov/pubmed/37627189
http://dx.doi.org/10.3390/cancers15164161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453285/
https://www.ncbi.nlm.nih.gov/pubmed/37627189
http://dx.doi.org/10.3390/cancers15164161

Ejemplares similares